| 1 |
34914264 | [Effects of silencing HMGB1 combined with docetaxel chemotherapy on the proliferation and apoptosis of prostate cancer cells and its action mechanism]. | 2021 Oct 20 |
3 |
| 2 |
32115500 | Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer. | 2020 |
4 |
| 3 |
30744691 | Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC. | 2019 Feb 11 |
6 |
| 4 |
27457217 | Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy. | 2016 Sep |
2 |
| 5 |
26469759 | HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells. | 2015 Oct 15 |
2 |
| 6 |
24996221 | HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma. | 2014 Jul 5 |
6 |
| 7 |
23410002 | Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer. | 2013 Mar |
4 |
| 8 |
23019417 | Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells. | 2012 Sep |
1 |